Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration With Merck

The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck, known as MSD outside of the United States and Canada, to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the pandemic.